38
Gunther Eysenbach MD MPH Gunther Eysenbach MD MPH Professor Institute for Health Policy, Management and Evaluation, University of Toronto; Senior Scientist, Centre for Global eHealth Innovation, Editor-in-chief, Journal of Medical Internet Research Publisher, JMIR Publications Producer, Medicine 2.0 Conference Series Co-Director, Communication & Knowledge Translation, Techna Institute Toronto General Hospital, Canada Visiting Professor, Faculty of Behavioural Sciences University of Twente, The Netherlands Ethics in Infodemiology and Public Health 2.0 @eysenbach @eysenbach Presented at #Epicrowd2015 Recife, Brazil 26 Mar 2015 http://www.slideshare.net/eysen

Ethics in Infodemiology and Public Health 2.0

Embed Size (px)

Citation preview

Page 1: Ethics in Infodemiology and Public Health 2.0

Gunther Eysenbach MD MPH

Gunther Eysenbach MD MPH

ProfessorInstitute for Health Policy, Management andEvaluation, University of Toronto;

Senior Scientist,Centre for Global eHealth Innovation,

Editor-in-chief, Journal of Medical Internet ResearchPublisher, JMIR PublicationsProducer, Medicine 2.0 Conference Series

Co-Director, Communication & Knowledge Translation, TechnaInstitute

Toronto General Hospital, Canada

Visiting Professor,Faculty of Behavioural SciencesUniversity of Twente, The Netherlands

Ethics in Infodemiology and Public Health 2.0

@eysenbach@eysenbach

Presented at#Epicrowd2015Recife, Brazil26 Mar 2015http://www.slideshare.net/eysen

Page 2: Ethics in Infodemiology and Public Health 2.0

www.jmir.org

Page 3: Ethics in Infodemiology and Public Health 2.0

JMIR has published >50 infodemiology studieshttp://www.jmir.org/themes/69

Page 4: Ethics in Infodemiology and Public Health 2.0

www.jmir.org

Page 5: Ethics in Infodemiology and Public Health 2.0

publichealth.jmir.org

Page 6: Ethics in Infodemiology and Public Health 2.0

An early paper on “infodemiology”: Internet searches correlate with Flu

Eysenbach, 2006

Page 7: Ethics in Infodemiology and Public Health 2.0

Eysenbach, Am J Prev Med 2011

Page 8: Ethics in Infodemiology and Public Health 2.0

Eysenbach, Am J Prev Med 2011

Page 9: Ethics in Infodemiology and Public Health 2.0

Chew & Eysenbach. PloS One 2010; 5(11)

Page 10: Ethics in Infodemiology and Public Health 2.0
Page 11: Ethics in Infodemiology and Public Health 2.0
Page 12: Ethics in Infodemiology and Public Health 2.0
Page 13: Ethics in Infodemiology and Public Health 2.0
Page 14: Ethics in Infodemiology and Public Health 2.0

Clash of cultures

• Industry practice– Users agree to Terms of Use giving widespread power

companies to do what they like with the data

– Users don’t read or understand TOS

– A/B testing (split-testing, mini-RCTs) routinely done without users’ knowledge and consent

– Tradeoff: Providing data vs getting free services

• Research best practice– Inform users

– Allow them to opt-out

Page 15: Ethics in Infodemiology and Public Health 2.0

The dilemma for journal editors

Wealth of data in the hands of private corporations

Best practice for research (informed consent/optout) often cannot be met

Page 16: Ethics in Infodemiology and Public Health 2.0
Page 17: Ethics in Infodemiology and Public Health 2.0

What about industry research?

Page 18: Ethics in Infodemiology and Public Health 2.0

Industry research committee

• Independent from researcher

• Preferably before research starts

• Not just rubberstamping but giving meaningful feedback

Page 19: Ethics in Infodemiology and Public Health 2.0

Why do we need IRBs/Industry Ethics Committees

• Harms vs benefit analysis

• Should be done by 3rd party, not researchers themselves

• Perceived harm / sense of wrongdoingFB study pushed all the wrong buttons:

– “Alter emotional states”

– “Secret experiment” (no disclosure/informed consent)

– “Funded by the military”

– Privacy concerns

Page 20: Ethics in Infodemiology and Public Health 2.0

N=1006, US population, poll conducted by JMIR Publications with Google Consumer Surveys

68% say FB should inform users and enable opt-out

Page 21: Ethics in Infodemiology and Public Health 2.0

Older people more likely to as for informed consent and opt-out

Page 22: Ethics in Infodemiology and Public Health 2.0

N=1002, US population, poll conducted by JMIR Publications with Google Consumer Surveys

Even for randomized design and functionality tests only 10% “don’t

mind” to be involved

24% want to opt out

10% don’t mind

14% were not aware

Page 23: Ethics in Infodemiology and Public Health 2.0

N=1003, US population, poll conducted by JMIR Publications with Google Consumer Surveys

Companies and gov monitor tweets to gather intelligence

27% want to opt out9% didn’t know5% agree if it’s for public health5% agree if it’s for government4% agree if it’s for companies

Page 24: Ethics in Infodemiology and Public Health 2.0

Perhaps it's like undressing in front of an open window and then being outraged that someone watched, but that sense of outrage is real. Perhaps it is also time to revisit

our ethical frameworks, which largely date to the predigital age, in the light of recent developments in data

collection and storage on the Internet.

Michael W. Ross, PhD, MD, MPH, is a professor of behavioral sciences at the Center for Health Promotion

and Prevention Research in the School of Public Health at the University of Texas. He is also a member of the APA

Committee on Human Research.

Page 25: Ethics in Infodemiology and Public Health 2.0

Eysenbach & Till, BMJ 2001

Page 26: Ethics in Infodemiology and Public Health 2.0

Eysenbach & Till, BMJ 2001

Page 27: Ethics in Infodemiology and Public Health 2.0

Conway. J Med Internet Res 2014http://www.jmir.org/2014/12/e290

Page 28: Ethics in Infodemiology and Public Health 2.0

Conway MEthical Issues in Using Twitter for Public Health Surveillance and Research: Developing a

Taxonomy of Ethical Concepts From the Research LiteratureJ Med Internet Res 2014;16(12):e290

URL: http://www.jmir.org/2014/12/e290DOI: 10.2196/jmir.3617

Page 29: Ethics in Infodemiology and Public Health 2.0

Cyberstudies / Public Health 2.0

• Passive Monitoring of tweets, social media and aggregated data monitoring

• Qualitative research of Internet communities

• Intervention studies such as altering the newsfeed

• Participatory Surveillance

Traditional Health Research

• Passive Monitoring of EMR, OTC drug sales, and aggregated data monitoring

• Qualitative research of consumer behavior

• Intervention studies such as behavior change studies

• Surveys

Explicit Informed ConsentOpt-out

Implicit Informed ConsentNo Opt-out

Page 30: Ethics in Infodemiology and Public Health 2.0

Some crazy ideas (1/2)

• Should there be an established voluntary standards for disclosure of experiments on websites – For example, companies such as FB should have a

standard URL such as facebook.com/research disclosing current research (A/B/ testing) and providing opt-out options

• Should responsible companies and researchers in this field agree on a code of conduct, provide notice and choice (opt-out infrastructure)

Page 31: Ethics in Infodemiology and Public Health 2.0

http://www.networkadvertising.org/choices/

Page 32: Ethics in Infodemiology and Public Health 2.0
Page 33: Ethics in Infodemiology and Public Health 2.0
Page 34: Ethics in Infodemiology and Public Health 2.0
Page 35: Ethics in Infodemiology and Public Health 2.0

Some questions (2/2)

• Should the research community define and honor a standard controlled vocabulary (hashtags) so users can indicate if their tweets/status updates can/should be used for aggregate analysis and research

Page 36: Ethics in Infodemiology and Public Health 2.0
Page 37: Ethics in Infodemiology and Public Health 2.0

Conclusions

• Only because information is “public”, or for honorable purposes such as public health, consumers may have issues with large-scale data analysis, esp. older people & for sensitive topics

• It takes only one poorly framed study to create a media/consumer backlash

• Consumer education as well as new “industry standards”, collaboration among researchers (role of funders?), and technical tools (opt-out/disclosure infrastructure) may be part of the answer

Page 38: Ethics in Infodemiology and Public Health 2.0

Gunther Eysenbach MD MPH

Gunther Eysenbach MD MPH

@eysenbach@eysenbach

[email protected]